These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 37202938)

  • 1. Dodecanoic acid & palmitic acid disarms rifampicin resistance by putatively targeting mycobacterial efflux pump Rv1218c.
    Nirmal CR; Rajadas SE; Balasubramanian M; Magdaline D; Chilamakuru NB; Dinesh R; Radhakrishnan A; Paraman R; Mondal R; Azger Dusthackeer VN
    Indian J Med Res; 2023; 157(2&3):192-203. PubMed ID: 37202938
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Myoinositol and methyl stearate increases rifampicin susceptibility among drug-resistant Mycobacterium tuberculosis expressing Rv1819c.
    Nirmal CR; Rajadas SE; Balasubramanian M; Mohanvel SK; Aathi MS; Munishankar S; Chilamakuru NB; Thiruvenkadam K; Pandiya Raj AK; Paraman R; Dusthackeer A
    Chem Biol Drug Des; 2023 Apr; 101(4):883-895. PubMed ID: 36533863
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Investigation of Efflux Pump Genes in Resistant Mycobacterium tuberculosis Complex Clinical Isolates Exposed to First Line Antituberculosis Drugs and Verapamil Combination].
    Özgür D; Ersoy L; Ülger M; Tezcan Ülger S; Aslan G
    Mikrobiyol Bul; 2023 Apr; 57(2):207-219. PubMed ID: 37067206
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The expression of ABC efflux pump, Rv1217c-Rv1218c, and its association with multidrug resistance of Mycobacterium tuberculosis in China.
    Wang K; Pei H; Huang B; Zhu X; Zhang J; Zhou B; Zhu L; Zhang Y; Zhou FF
    Curr Microbiol; 2013 Mar; 66(3):222-6. PubMed ID: 23143285
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rifampicin reduces susceptibility to ofloxacin in rifampicin-resistant Mycobacterium tuberculosis through efflux.
    Louw GE; Warren RM; Gey van Pittius NC; Leon R; Jimenez A; Hernandez-Pando R; McEvoy CR; Grobbelaar M; Murray M; van Helden PD; Victor TC
    Am J Respir Crit Care Med; 2011 Jul; 184(2):269-76. PubMed ID: 21512166
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Contribution of efflux to the emergence of isoniazid and multidrug resistance in Mycobacterium tuberculosis.
    Machado D; Couto I; Perdigão J; Rodrigues L; Portugal I; Baptista P; Veigas B; Amaral L; Viveiros M
    PLoS One; 2012; 7(4):e34538. PubMed ID: 22493700
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression analysis of 10 efflux pump genes in multidrug-resistant and extensively drug-resistant Mycobacterium tuberculosis clinical isolates.
    Kardan-Yamchi J; Kazemian H; Haeili M; Harati AA; Amini S; Feizabadi MM
    J Glob Antimicrob Resist; 2019 Jun; 17():201-208. PubMed ID: 30654147
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Microarray analysis of efflux pump genes in multidrug-resistant Mycobacterium tuberculosis during stress induced by common anti-tuberculous drugs.
    Gupta AK; Katoch VM; Chauhan DS; Sharma R; Singh M; Venkatesan K; Sharma VD
    Microb Drug Resist; 2010 Mar; 16(1):21-8. PubMed ID: 20001742
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differential Expression of Resistant and Efflux Pump Genes in MDR-TB Isolates.
    AlMatar M; Var I; Kayar B; Köksal F
    Endocr Metab Immune Disord Drug Targets; 2020; 20(2):271-287. PubMed ID: 31595857
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Performance comparison of four methods for detecting multidrug-resistant Mycobacterium tuberculosis strains.
    Al-Mutairi NM; Ahmad S; Mokaddas E
    Int J Tuberc Lung Dis; 2011 Jan; 15(1):110-5. PubMed ID: 21276306
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ofloxacin resistance in Mycobacterium tuberculosis is associated with efflux pump activity independent of resistance pattern and genotype.
    Sun Z; Xu Y; Sun Y; Liu Y; Zhang X; Huang H; Li C
    Microb Drug Resist; 2014 Dec; 20(6):525-32. PubMed ID: 24940805
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecular and phenotypic characterisation of Mycobacterium tuberculosis resistant to anti-tuberculosis drugs.
    Imperiale BR; Zumárraga MJ; Di Giulio AB; Cataldi AA; Morcillo NS
    Int J Tuberc Lung Dis; 2013 Aug; 17(8):1088-93. PubMed ID: 23827034
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reevaluating Rifampicin Breakpoint Concentrations for Mycobacterium tuberculosis Isolates with Disputed
    Wang W; Liu R; Yao C; Huo F; Shang Y; Zhang X; Wang Y; Xue Z; Ma L; Pang Y
    Microbiol Spectr; 2022 Feb; 10(1):e0208721. PubMed ID: 35107324
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Validation of the line-probe assay for rapid detection of rifampicin-resistant Mycobacterium tuberculosis in Vietnam.
    Shah NS; Lan NT; Huyen MN; Laserson K; Iademarco MF; Binkin N; Wells C; Varma JK
    Int J Tuberc Lung Dis; 2009 Feb; 13(2):247-52. PubMed ID: 19146755
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rifampicin-resistant Mycobacterium tuberculosis: susceptibility to isoniazid and other anti-tuberculosis drugs.
    Kurbatova EV; Cavanaugh JS; Shah NS; Wright A; Kim H; Metchock B; Van Deun A; Barrera L; Boulahbal F; Richter E; Martín-Casabona N; Arias F; Zemanova I; Drobniewski F; Santos Silva A; Coulter C; Lumb R; Cegielski JP
    Int J Tuberc Lung Dis; 2012; 16(3):355-7. PubMed ID: 22640449
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterization of Mutations Conferring Resistance to Rifampin in Mycobacterium tuberculosis Clinical Strains.
    Jagielski T; Bakuła Z; Brzostek A; Minias A; Stachowiak R; Kalita J; Napiórkowska A; Augustynowicz-Kopeć E; Żaczek A; Vasiliauskiene E; Bielecki J; Dziadek J
    Antimicrob Agents Chemother; 2018 Oct; 62(10):. PubMed ID: 30061294
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Occurrence of disputed rpoB mutations among Mycobacterium tuberculosis isolates phenotypically susceptible to rifampicin in a country with a low incidence of multidrug-resistant tuberculosis.
    Al-Mutairi NM; Ahmad S; Mokaddas E; Eldeen HS; Joseph S
    BMC Infect Dis; 2019 Jan; 19(1):3. PubMed ID: 30606116
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecular detection of multidrug resistance pattern and associated gene mutations in M. tuberculosis isolates from newly diagnosed pulmonary tuberculosis patients in Addis Ababa, Ethiopia.
    Tilahun M; Shimelis E; Wogayehu T; Assefa G; Wondimagegn G; Mekonnen A; Hailu T; Bobosha K; Aseffa A
    PLoS One; 2020; 15(8):e0236054. PubMed ID: 32750053
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Potential impact of efflux pump genes in mediating rifampicin resistance in clinical isolates of Mycobacterium tuberculosis from India.
    Narang A; Garima K; Porwal S; Bhandekar A; Shrivastava K; Giri A; Sharma NK; Bose M; Varma-Basil M
    PLoS One; 2019; 14(9):e0223163. PubMed ID: 31557231
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Novel rrs mutations in second-line injectable drug-resistant clinical isolates of Mycobacterium tuberculosis from the Punjab province of Pakistan.
    Sarwer MI; Khan MT; Khurshid S
    J Infect Chemother; 2022 Aug; 28(8):1119-1124. PubMed ID: 35428575
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.